These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®. Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441 [TBL] [Abstract][Full Text] [Related]
24. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect. Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342 [TBL] [Abstract][Full Text] [Related]
25. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance. Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509 [TBL] [Abstract][Full Text] [Related]
26. Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO Ding L; Li J; Huang R; Liu Z; Li C; Yao S; Wang J; Qi D; Li N; Pi J Int J Nanomedicine; 2016; 11():5709-5727. PubMed ID: 27843313 [TBL] [Abstract][Full Text] [Related]
27. Effect of the Folate Ligand Density on the Targeting Property of Folated-Conjugated Polymeric Nanoparticles. Gong YC; Xiong XY; Ge XJ; Li ZL; Li YP Macromol Biosci; 2019 Feb; 19(2):e1800348. PubMed ID: 30444303 [TBL] [Abstract][Full Text] [Related]
28. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Chen J; Li S; Shen Q; He H; Zhang Y Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153 [TBL] [Abstract][Full Text] [Related]
29. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer. He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149 [TBL] [Abstract][Full Text] [Related]
30. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability. Zhao J; Du J; Wang J; An N; Zhou K; Hu X; Dong Z; Liu Y ACS Appl Mater Interfaces; 2021 Mar; 13(12):14577-14586. PubMed ID: 33728919 [TBL] [Abstract][Full Text] [Related]
31. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers. Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931 [TBL] [Abstract][Full Text] [Related]
32. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer. Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543 [TBL] [Abstract][Full Text] [Related]
33. Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells. Pillai JJ; Thulasidasan AK; Anto RJ; Chithralekha DN; Narayanan A; Kumar GS J Nanobiotechnology; 2014 Jul; 12():25. PubMed ID: 25026938 [TBL] [Abstract][Full Text] [Related]
34. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy. Zhang G; Liu F; Jia E; Jia L; Zhang Y Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422 [TBL] [Abstract][Full Text] [Related]
35. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery. Wu T; Gong Y; Li Z; Li Y; Xiong X Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742 [TBL] [Abstract][Full Text] [Related]
36. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation. Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496 [TBL] [Abstract][Full Text] [Related]
37. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment. Song B; Wu S; Li W; Chen D; Hu H Pharm Res; 2020 Nov; 37(12):242. PubMed ID: 33188481 [TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo. Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415 [TBL] [Abstract][Full Text] [Related]
39. Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics. Li YJ; Dong M; Kong FM; Zhou JP Int J Pharm; 2015 Jul; 489(1-2):83-90. PubMed ID: 25888801 [TBL] [Abstract][Full Text] [Related]
40. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification. Zhang S; Tang C; Yin C Drug Deliv; 2015 Feb; 22(2):182-90. PubMed ID: 24215373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]